A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder

NCT00997087 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Study completed and data was inconclusive.

Conditions

Obsessive Compulsive Disorder

Interventions

DRUG: Flumazenil

Sponsor

Parkway Medical Center